Loading live market data…

Cinemark Holdings, Inc.

NYSE:CNK

$29.37 USD

$0.22 (0.75%)

Volume
2.08M
Average Volume
2.26M
Market Capitalization
$3.43B
P/E Ratio
19.98
Dividend Yield
1.19%
Price Target
$36.00
Year High
$34.73
Year Low
$21.60
Day High
Day Low
Payout Ratio
$0.23
Current Ratio
$0.62
Source Headline
4 Film & Television Production Stocks to Watch Amid Dull Industry Trends

Film and television production and distribution companies like WMG, NWSA, CNK and CURI are thriving despite heavy spending on original programming and exclusive rights.

zacks.com - 2026-07-14 10:56:41

This Cinemark Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

benzinga.com - 2026-07-09 07:32:16

Looking for a Growth Stock? 3 Reasons Why Cinemark (CNK) is a Solid Choice

Cinemark (CNK) possesses solid growth attributes, which could help it handily outperform the market.

zacks.com - 2026-07-07 13:45:25

Cinemark Lassos All-Time High Domestic Box Office Opening Weekend for a Family Film with Toy Story 5

PLANO, Texas--(BUSINESS WIRE)--Cinemark Holdings, Inc. (NYSE: CNK), one of the largest and most influential theatrical exhibition companies in the world, today announced it roped in its all-time biggest three-day opening weekend domestic box office for a G- or PG-rated film with Toy Story 5. Strong carryover from recent releases like Disclosure Day and Obsession contributed to Cinemark delivering its best-ever domestic June weekend box office as well as the top-performing box office weekend of the year.

businesswire.com - 2026-06-22 08:00:00

If I Can't Talk You Into Buying AMC This Summer, How About Cinemark, IMAX, or EPR?

Movie theaters are having their strongest year since 2019. Patrons are back. Investors should follow.

fool.com - 2026-06-04 11:53:00

Cinemark Reaches All-Time High Domestic Box Office for May

PLANO, Texas--(BUSINESS WIRE)-- #Cinemark--Cinemark Holdings, Inc. (NYSE: CNK), one of the largest and most influential theatrical exhibition companies in the world, today announced it delivered its highest-ever domestic box office performance for the month of May. These record-level results were fueled by broad moviegoer enthusiasm and the company's strategic programming of a well-balanced slate that included blockbusters, breakout mid-tier content and strong holdovers. The month was marked by exceptional.

businesswire.com - 2026-06-01 08:00:00

If Spider-Man Wins 2026's Box Office Crown, These Stocks Win Too

Prediction market traders have a clear favorite for 2026's box office crown, and the ripple effects extend well beyond Hollywood.

247wallst.com - 2026-05-29 08:50:03

Helix Partners Exits Reported Cinemark Holdings Stake, According to Recent SEC Filing

More moviegoers helped Cinemark, but the economics do not stop at the ticket counter. Concessions and premium formats are central to whether higher attendance becomes stronger operating leverage.

fool.com - 2026-05-26 16:26:36

LOAM ENTERTAINMENT'S 'BAD COUNSELORS' ARRIVES IN THEATRES NATIONWIDE JULY 23-27 FROM FATHOM ENTERTAINMENT

A Feel-Good Summer Comedy From Director Chris Dowling Stars Chris Klein, Matt Cornett & Ramon Reed NASHVILLE, Tenn. and DENVER, May 19, 2026 /PRNewswire/ -- When two hard-partying fraternity brothers pose as Christian camp counselors to work off court-ordered community service, the summer quickly becomes more than either of them bargained for.

prnewswire.com - 2026-05-19 11:00:00

Cinemark: Earnings Growth Path Looks More Credible Now

Cinemark remains a buy as Q1 2026 results validate the earnings recovery thesis, with strong revenue and EBITDA growth. CNK leverages premium formats, alternative content, and Movie Club to drive higher per-customer spend and repeat visits, reducing reliance on Hollywood film supply. US attendance and spend per patron improved significantly, while international attendance lagged, but pricing and concessions offset declines.

seekingalpha.com - 2026-05-14 19:15:52

Cinemark Declares Quarterly Cash Dividend of $0.09

PLANO, Texas--(BUSINESS WIRE)--Cinemark Holdings, Inc. (“Cinemark”) (NYSE: CNK), one of the largest and most influential theatrical exhibition companies in the world, announced today that its Board of Directors has declared a quarterly cash dividend of $0.09 per share of common stock. The dividend will be paid on June 11, 2026 to stockholders of record on May 28, 2026. About Cinemark Holdings, Inc.: Cinemark Holdings, Inc. (NYSE: CNK) provides extraordinary out-of-home entertainment experiences.

businesswire.com - 2026-05-14 16:30:00

3 Reasons Why Cinemark (CNK) Is a Great Growth Stock

Cinemark (CNK) could produce exceptional returns because of its solid growth attributes.

zacks.com - 2026-05-05 13:46:09

All You Need to Know About Cinemark (CNK) Rating Upgrade to Strong Buy

Cinemark (CNK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

zacks.com - 2026-05-05 13:01:18

New Strong Buy Stocks for May 5th

WKC, VAC, CLAR, CNK and GMED have been added to the Zacks Rank #1 (Strong Buy) List on May 5, 2026.

zacks.com - 2026-05-05 07:15:35

Cinemark Holdings, Inc. (CNK) Q1 2026 Earnings Call Transcript

Cinemark Holdings, Inc. (CNK) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-01 12:11:45

Compared to Estimates, Cinemark (CNK) Q1 Earnings: A Look at Key Metrics

Although the revenue and EPS for Cinemark (CNK) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

zacks.com - 2026-05-01 11:31:06

Cinemark Holdings (CNK) Reports Q1 Loss, Tops Revenue Estimates

Cinemark Holdings (CNK) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.32 per share a year ago.

zacks.com - 2026-05-01 08:41:08

Cinemark Holdings, Inc. Reports First Quarter 2026 Earnings Results

PLANO, Texas--(BUSINESS WIRE)--Cinemark Holdings, Inc. (“Cinemark”) (NYSE: CNK), one of the largest and most influential theatrical exhibition companies in the world, today reported results for the three months ended March 31, 2026. In conjunction with the earnings release, Cinemark published its first quarter executive commentary, which can be accessed on Cinemark's Investor Relations website at ir.cinemark.com under financial results. Conference Call Cinemark will host a public audio webcast.

businesswire.com - 2026-05-01 06:30:00

Analysts Estimate Live Nation (LYV) to Report a Decline in Earnings: What to Look Out for

Live Nation (LYV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-04-28 11:10:13

Are Consumer Discretionary Stocks Lagging Cinemark (CNK) This Year?

Here is how Cinemark Holdings (CNK) and Escalade (ESCA) have performed compared to their sector so far this year.

zacks.com - 2026-04-28 10:44:18

Cinemark Holdings (CNK) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Cinemark (CNK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-04-24 11:02:07

Assetmark Inc. Has $2.40 Million Position in Cinemark Holdings Inc $CNK

Assetmark Inc. trimmed its stake in shares of Cinemark Holdings Inc (NYSE: CNK) by 26.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 103,147 shares of the company's stock after selling 36,646 shares during the quarter.

defenseworld.net - 2026-04-21 03:24:53

Cinemark to Host First Quarter 2026 Earnings Conference Call

PLANO, Texas--(BUSINESS WIRE)--Cinemark Holdings, Inc. (“Cinemark”) (NYSE: CNK), one of the largest and most influential theatrical exhibition companies in the world, today announced that it will report its first quarter 2026 operating results and associated executive commentary pre-market and host a webcast to discuss the results on: Friday, May 1, 2026 8:30 a.m. Eastern Time Interested parties can listen to the call via live webcast. Please access 5-10 minutes before the call: https://event.c.

businesswire.com - 2026-04-17 08:30:00

Get CNK Insider Trade Alerts

CNK Price Target Summary

Last Month

$33.50

2 analysts

Last Quarter

$34.00

5 analysts

Last Year

$32.80

15 analysts

All Time

$29.42

33 analysts

CNK Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-07-09 Goldman Sachs Upgrade Sell Neutral
2026-07-08 Macquarie Maintain Outperform Outperform
2026-06-17 Benchmark Maintain Buy Buy
2026-06-11 B. Riley Securities Maintain Neutral Neutral
2026-06-09 Morgan Stanley Maintain Equal Weight Equal Weight
2026-05-04 Barrington Research Maintain Outperform Outperform
2026-05-04 Macquarie Maintain Outperform Outperform
2026-05-04 JP Morgan Maintain Overweight Overweight
2026-04-30 Morgan Stanley Maintain Equal Weight Equal Weight
2026-04-09 Wells Fargo Maintain Overweight Overweight
2026-04-08 JP Morgan Maintain Overweight Overweight
2026-02-19 Barrington Research Maintain Outperform Outperform
2026-02-18 Macquarie Maintain Outperform Outperform
2026-01-26 Barrington Research Maintain Outperform Outperform
2026-01-22 B. Riley Securities Maintain Neutral Neutral
2026-01-22 JP Morgan Maintain Overweight Overweight
2026-01-15 Macquarie Maintain Outperform Outperform
2026-01-14 Wells Fargo Maintain Overweight Overweight
2025-12-18 Morgan Stanley Downgrade Overweight Equal Weight
2025-11-06 JP Morgan Maintain Overweight Overweight
2025-10-21 Morgan Stanley Maintain Overweight Overweight
2025-10-09 JP Morgan Maintain Overweight Overweight
2025-09-23 Barrington Research Maintain Outperform Outperform
2025-08-04 Wells Fargo Maintain Overweight Overweight
2025-08-04 Roth Capital Maintain Buy Buy
2025-08-04 Barrington Research Maintain Outperform Outperform
2025-07-11 Wedbush Upgrade Neutral Outperform
2025-07-09 Roth Capital Maintain Buy Buy
2025-07-02 Benchmark Maintain Buy Buy
2025-05-05 Barrington Research Maintain Outperform Outperform
2025-05-05 JP Morgan Maintain Overweight Overweight
2025-04-28 Wedbush Maintain Neutral Neutral
2025-04-11 JP Morgan Upgrade Neutral Overweight
2025-02-20 Morgan Stanley Maintain Overweight Overweight
2025-02-20 Macquarie Maintain Outperform Outperform
2025-02-20 Barrington Research Maintain Outperform Outperform
2025-02-20 JP Morgan Maintain Neutral Neutral
2025-02-20 Benchmark Maintain Buy Buy
2025-02-19 Barrington Research Maintain Outperform Outperform
2025-01-30 JP Morgan Maintain Neutral Neutral
2025-01-29 Wells Fargo Maintain Overweight Overweight
2025-01-10 Benchmark Maintain Buy Buy
2024-12-18 Morgan Stanley Maintain Overweight Overweight
2024-12-03 Benchmark Maintain Buy Buy
2024-11-27 Wells Fargo Maintain Overweight Overweight
2024-11-04 Barrington Research Maintain Outperform Outperform
2024-11-01 Wells Fargo Maintain Overweight Overweight
2024-11-01 Macquarie Maintain Outperform Outperform
2024-11-01 Wedbush Downgrade Outperform Neutral
2024-10-31 Barrington Research Upgrade Market Perform Outperform
2024-10-29 Wedbush Maintain Outperform Outperform
2024-10-14 JP Morgan Maintain Neutral Neutral
2024-10-11 Morgan Stanley Maintain Overweight Overweight
2024-10-10 Roth MKM Maintain Buy Buy
2024-10-10 Wells Fargo Maintain Overweight Overweight
2024-09-19 Goldman Sachs Maintain Sell Sell
2024-09-03 Wedbush Maintain Outperform Outperform
2024-08-28 Barrington Research Downgrade Outperform Market Perform
2024-08-27 B. Riley Securities Downgrade Buy Neutral
2024-08-05 Roth MKM Maintain Buy Buy
2024-08-05 B. Riley Securities Maintain Buy Buy
2024-08-05 JP Morgan Maintain Neutral Neutral
2024-08-05 Morgan Stanley Maintain Overweight Overweight
2024-08-05 Barrington Research Maintain Outperform Outperform
2024-08-02 Barrington Research Maintain Outperform Outperform
2024-07-29 Wedbush Maintain Outperform Outperform
2024-07-18 Morgan Stanley Maintain Overweight Overweight
2024-07-09 Macquarie Maintain Outperform Outperform
2024-07-08 B. Riley Securities Upgrade Neutral Buy
2024-07-01 Benchmark Maintain Buy Buy
2024-06-27 Wedbush Maintain Outperform Outperform
2024-06-24 Roth MKM Upgrade Neutral Buy
2024-06-17 Barrington Research Maintain Outperform Outperform
2024-05-03 Benchmark Maintain Buy Buy
2024-05-03 B. Riley Securities Maintain Neutral Neutral
2024-04-25 Wedbush Maintain Outperform Outperform
2024-04-22 Barrington Research Maintain Outperform Outperform
2024-04-18 Wedbush Maintain Outperform Outperform
2024-04-10 Benchmark Maintain Buy Buy
2024-04-10 Roth MKM Maintain Neutral Neutral
2024-04-08 JP Morgan Maintain Neutral Neutral
2024-04-05 Wells Fargo Upgrade Underweight Overweight
2024-04-03 Benchmark Maintain Buy Buy
2024-02-13 Wedbush Maintain Outperform Outperform
2024-02-06 JP Morgan Maintain Neutral Neutral
2024-01-11 Goldman Sachs Maintain Sell Sell
2024-01-02 B. Riley Securities Downgrade Buy Neutral
2023-12-20 Wells Fargo Downgrade Equal Weight Underweight
2023-10-24 Wells Fargo Maintain Equal Weight Equal Weight
2023-10-06 Benchmark Maintain Buy Buy
2023-09-19 Benchmark Maintain Buy Buy
2023-08-07 Wedbush Maintain Outperform Outperform
2023-08-07 Barrington Research Maintain Outperform Outperform
2023-08-07 Morgan Stanley Maintain Overweight Overweight
2023-08-01 Wedbush Maintain Outperform Outperform
2023-07-19 JP Morgan Downgrade Overweight Neutral
2023-07-18 Morgan Stanley Maintain Overweight Overweight
2023-07-12 B. Riley Securities Upgrade Neutral Buy
2023-07-12 Roth MKM Maintain Neutral Neutral
2023-07-10 Benchmark Maintain Buy Buy
2023-06-14 B. Riley Securities Downgrade Buy Neutral
2023-05-26 Benchmark Maintain Buy Buy
2023-05-09 Barrington Research Maintain Outperform Outperform
2023-05-08 B. Riley Securities Maintain Buy Buy
2023-05-08 Macquarie Maintain Outperform Outperform
2023-05-08 Morgan Stanley Maintain Overweight Overweight
2023-04-21 Goldman Sachs Maintain Sell Sell
2023-04-17 Morgan Stanley Maintain Overweight Overweight
2023-04-10 B. Riley Securities Maintain Buy Buy
2023-04-06 Credit Suisse Maintain Neutral Neutral
2023-02-27 JP Morgan Maintain Overweight Overweight
2023-02-27 B. Riley Securities Maintain Buy Buy
2023-02-23 Credit Suisse Upgrade Underperform Neutral
2023-01-12 JP Morgan Upgrade Neutral Overweight
2022-12-21 Benchmark Maintain Buy Buy
2022-11-07 Wells Fargo Maintain Equal Weight Equal Weight
2022-10-27 Morgan Stanley Maintain Overweight Overweight
2022-10-12 Credit Suisse Downgrade Outperform Underperform
2022-10-11 Goldman Sachs Maintain Sell Sell
2022-10-10 JP Morgan Maintain Neutral Neutral
2022-08-08 Wells Fargo Maintain Equal Weight Equal Weight
2022-07-19 Morgan Stanley Upgrade Equal Weight Overweight
2022-06-21 B. Riley Securities Maintain Buy Buy
2022-04-13 B. Riley Securities Maintain Buy Buy
2022-03-07 Goldman Sachs Maintain Sell Sell
2022-02-28 Wells Fargo Maintain Equal Weight Equal Weight
2021-12-15 Morgan Stanley Maintain Equal Weight Equal Weight
2021-11-09 Credit Suisse Upgrade Neutral Outperform
2021-10-15 Morgan Stanley Maintain Equal Weight Equal Weight
2021-07-29 Morgan Stanley Maintain Equal Weight Equal Weight
2021-06-02 Goldman Sachs Downgrade Neutral Sell
2021-04-19 Morgan Stanley Maintain Equal Weight Equal Weight
2021-02-01 MKM Partners Downgrade Buy Neutral
2021-01-15 B. Riley FBR Upgrade Neutral Buy
2021-01-14 B. Riley Securities Upgrade Neutral Buy
2020-11-19 Loop Capital Downgrade Buy Hold
2020-11-04 Morgan Stanley Maintain Equal Weight Equal Weight
2020-10-26 Barrington Research Downgrade Outperform Market Perform
2020-10-09 MKM Partners Maintain Buy Buy
2020-08-20 Benchmark Upgrade Hold Buy
2020-08-03 Morgan Stanley Maintain Equal Weight Equal Weight
2020-07-13 MKM Partners Maintain Buy Buy
2020-06-29 Credit Suisse Downgrade Outperform Neutral
2020-06-19 Imperial Capital Maintain Outperform Outperform
2020-06-04 Credit Suisse Maintain Outperform Outperform
2020-06-04 MKM Partners Maintain Buy Buy
2020-06-01 Morgan Stanley Maintain Equal Weight Equal Weight
2020-05-26 Imperial Capital Maintain Outperform Outperform
2020-05-18 B. Riley Securities Downgrade Buy Neutral
2020-05-18 B. Riley FBR Downgrade Buy Neutral
2020-04-16 B. Riley Securities Maintain Buy Buy
2020-04-16 B. Riley FBR Maintain Buy Buy
2020-04-06 B. Riley Securities Upgrade Neutral Buy
2020-04-06 B. Riley Upgrade Neutral Buy
2020-04-06 B. Riley FBR Upgrade Neutral Buy
2020-04-01 B. Riley Securities Maintain Neutral Neutral
2020-04-01 B. Riley FBR Maintain Neutral Neutral
2020-03-25 Morgan Stanley Maintain Equal Weight Equal Weight
2020-03-25 Imperial Capital Maintain Outperform Outperform
2020-03-24 Credit Suisse Maintain Outperform Outperform
2020-03-20 Wedbush Maintain Outperform Outperform
2020-03-18 B. Riley FBR Maintain Neutral Neutral
2020-03-18 B. Riley Securities Maintain Neutral Neutral
2020-03-17 JP Morgan Downgrade Overweight Neutral
2020-03-06 MKM Partners Maintain Buy Buy
2020-02-24 Morgan Stanley Maintain Equal Weight Equal Weight
2020-02-24 JP Morgan Maintain Overweight Overweight
2020-02-24 B. Riley FBR Maintain Neutral Neutral
2020-02-24 B. Riley Securities Maintain Neutral Neutral
2020-02-03 Wedbush Maintain Outperform Outperform
2019-11-22 B. Riley FBR Downgrade Buy Neutral
2019-11-22 B. Riley Securities Downgrade Buy Neutral
2019-09-10 MKM Partners Maintain Buy Buy
2019-07-23 Morgan Stanley Maintain Equal Weight Equal Weight
2019-07-03 Loop Capital Upgrade Hold Buy
2018-11-05 B. Riley FBR Maintain Buy Buy
2018-11-05 RBC Capital Maintain Outperform Outperform
2018-11-05 B. Riley Securities Maintain Buy Buy
2018-10-18 Morgan Stanley Maintain Equal Weight Equal Weight
2018-07-23 Morgan Stanley Maintain Equal Weight Equal Weight
2018-05-09 Morgan Stanley Maintain Equal Weight Equal Weight
2018-05-05 B. Riley FBR Upgrade Neutral Buy
2018-05-05 B. Riley FBR Downgrade Buy Neutral
2018-05-05 B. Riley FBR Maintain Buy Buy
2018-01-31 Morgan Stanley Maintain Equal Weight Equal Weight
2018-01-10 RBC Capital Upgrade Sector Perform Outperform
2017-10-18 B. Riley FBR Maintain Buy Buy
2017-10-18 B. Riley Securities Maintain Buy Buy
2017-10-05 Morgan Stanley Upgrade Underweight Equal Weight
2017-09-28 Credit Suisse Maintain Underperform Underperform
2017-07-26 Wedbush Upgrade Neutral Outperform
2017-06-22 Credit Suisse Downgrade Neutral Underperform
2017-04-03 FBR Capital Downgrade Outperform Market Perform
2017-03-22 Wunderlich Securities Downgrade Buy Hold
2017-03-22 Wunderlich Downgrade Buy Hold
2017-02-27 RBC Capital Downgrade Outperform Sector Perform
2016-10-31 Goldman Sachs Upgrade Neutral Buy
2016-08-10 Drexel Hamilton Downgrade Buy Hold
2016-08-04 B. Riley FBR Upgrade Neutral Buy
2016-08-04 B. Riley Securities Upgrade Neutral Buy
2016-04-04 JP Morgan Maintain Overweight Overweight
2016-03-30 B. Riley FBR Downgrade Buy Neutral
2016-03-30 B. Riley Securities Downgrade Buy Neutral
2016-03-17 Moffett Nathanson Downgrade Buy Neutral
2016-03-17 MoffettNathanson Downgrade Buy Neutral
2016-03-03 Benchmark Downgrade Buy Hold
2015-10-15 Morgan Stanley Downgrade Equal Weight Underweight
2015-09-28 Stifel Nicolaus Maintain Buy Buy
2015-09-28 Stifel Maintain Buy Buy
2015-08-21 FBR Capital Maintain Outperform Outperform
2015-08-10 RBC Capital Maintain Outperform Outperform
2015-06-09 Topeka Upgrade Hold Buy
2015-06-09 Topeka Capital Upgrade Hold Buy
2015-05-08 RBC Capital Maintain Outperform Outperform
2015-04-08 Janney Capital Downgrade Buy Neutral
2015-04-08 Janney Montgomery Scott Downgrade Buy Neutral
2015-02-19 JP Morgan Maintain Overweight Overweight
2014-11-26 Topeka Capital Downgrade Buy Hold
2014-11-26 Topeka Downgrade Buy Hold
2014-09-06 Morgan Stanley Maintain Equal Weight Equal Weight
2014-09-03 Stifel Upgrade Hold Buy
2014-09-03 Stifel Nicolaus Upgrade Hold Buy
2014-08-13 Wunderlich Securities Maintain Buy Buy
2014-08-13 Wunderlich Maintain Buy Buy
2014-07-07 B. Riley Securities Downgrade Buy Neutral
2014-07-07 B. Riley FBR Downgrade Buy Neutral
2014-06-30 JP Morgan Maintain Overweight Overweight
2014-05-27 B. Riley Securities Upgrade Neutral Buy
2014-05-27 B. Riley FBR Upgrade Neutral Buy
2014-02-10 JP Morgan Upgrade Neutral Overweight
2013-11-12 Janney Montgomery Scott Upgrade Neutral Buy
2013-11-12 Janney Capital Upgrade Neutral Buy
2013-08-13 Wunderlich Securities Maintain Buy Buy
2013-08-13 Wunderlich Maintain Buy Buy
2013-05-08 Nomura Maintain Buy Buy
2013-03-25 Nomura Maintain Buy Buy
2013-03-04 B. Riley FBR Downgrade Buy Neutral
2013-03-04 B. Riley Securities Downgrade Buy Neutral
2013-02-21 Janney Montgomery Scott Downgrade Buy Neutral
2013-02-21 Janney Capital Downgrade Buy Neutral
2013-01-15 Nomura Maintain Buy Buy
2012-12-03 JP Morgan Downgrade Overweight Neutral
2012-11-12 Morgan Stanley Maintain Equal Weight Equal Weight
2012-11-07 Goldman Sachs Maintain Neutral Neutral
2012-11-07 Wunderlich Securities Maintain Buy Buy
2012-11-07 Wunderlich Maintain Buy Buy
2012-11-07 Janney Montgomery Scott Upgrade Neutral Buy
2012-11-07 Nomura Maintain Buy Buy
2012-11-07 Janney Capital Upgrade Neutral Buy
2012-11-06 Wedbush Maintain Neutral Neutral
2012-10-03 Barrington Research Maintain Outperform Outperform
2012-08-07 Goldman Sachs Maintain Neutral Neutral
2012-07-18 Stifel Nicolaus Downgrade Buy Hold
2012-07-18 Stifel Downgrade Buy Hold
2012-05-11 Barrington Research Maintain Outperform Outperform
2012-04-25 Morgan Stanley Maintain Equal Weight Equal Weight
2012-04-04 Wedbush Maintain Neutral Neutral